Notice: Undefined index: HTTP_ACCEPT_LANGUAGE in /DATA/web/docroots/ on line 40
About us
This site is dedicated to scientific community working on ALS. Our aim is to optimize researchers time and efforts by providing updated, well organized information on novel findings, available resources and research support.
AriSLA - The Foundation for research on ALS - has been set up to make ALS research investments more effective and efficient, to speed up the clinical research impact e and to provide patients with better care, improved conditions and life expectancy. Its aim is to boost Italian excellencies in basic, clinical and technological research. The Foundation founders are Fondazione Cariplo, Fondazione Telethon, Fondazione Vialli and Mauro and AISLA.



Atypical dementias: from diagnosis to emerging therapies

International center for genetic engineering and biotechnologies, the Arturo Falaschi Conference series

Dementia represents the most common neurodegenerative disorder affecting approximately 5% of the elderly population over age 65 years. At present, different forms of dementia are distinguished, including Alzheimer's disease (AD), dementia with Lewy bodies, frontotemporal dementia, corticobasal degeneration, progressive nuclear palsy and Parkinson dementia. Often these atypical dementias are associated with neurological symptoms and with motor neuron disease. Today, understanding the molecular basis of such dementias, their diagnosis, clinical implications, and diagnostic issues, is one of the most pressing needs worldwide. For this reason, the meeting topics are of high interest for the whole scientific community.

The meeting will foster targeted emerging areas of research in the field of atypical dementias. In parallel, it also aims at integrating and disseminating current knowledge on the subject.
The meeting will tackle several forms of atypical dementia that are on the rise in both developed and developing countries. Discussions will include leading conceptual advances that arise from the study of early and late stage pathological neurodegeneration. As a result, the meeting is positioned to provide invaluable guidance to other scientists, governing bodies, and the general public on the best ways of lessening the impact of dementia, both at the macro-economic and at the individual human level.

Topics of the sessions will include:

  • Frontotemporal Dementia
  • Frontotemporal dementia with Motor Neuron Disease
  • Early onset Alzheimer's disease and Cerebral Amyloid Angiopathy
  • Dementia with Lewy Bodies and Parkinson Disease Dementia
  • Rare forms of dementia

For more information about the event




Powered by Sofonisba